REFERENCES
1. Zani A, Chung WK, Deprest J, et al. Congenital diaphragmatic hernia. Nat Rev Dis Primers. 2022;8:37.
2. Donahoe PK, Longoni M, High FA. Polygenic causes of congenital diaphragmatic hernia produce common lung pathologies. Am J Pathol. 2016;186:2532-43.
3. Deprest JA, Nicolaides KH, Benachi A, et al; TOTAL Trial for Severe Hypoplasia Investigators. Randomized trial of fetal surgery for severe left diaphragmatic hernia. N Engl J Med. 2021;385:107-18.
4. Russo FM, Debeer A, De Coppi P, et al. What should we tell parents? Prenat Diagn. 2022;42:398-407.
5. Antounians L, Catania VD, Montalva L, et al. Fetal lung underdevelopment is rescued by administration of amniotic fluid stem cell extracellular vesicles in rodents. Sci Transl Med. 2021;13:eaax5941.
6. Khalaj K, Figueira RL, Antounians L, et al. Treatment with amniotic fluid stem cell extracellular vesicles promotes fetal lung branching and cell differentiation at canalicular and saccular stages in experimental pulmonary hypoplasia secondary to congenital diaphragmatic hernia. Stem Cells Transl Med. 2022;11:1089-102.
7. Khalaj K, Antounians L, Figueira RL, Post M, Zani A. Autophagy is impaired in fetal hypoplastic lungs and rescued by administration of amniotic fluid stem cell extracellular vesicles. Am J Respir Crit Care Med. 2022;206:476-87.
8. Antounians L, Figueira RL, Kukreja B, et al. Fetal hypoplastic lungs have multilineage inflammation that is reversed by amniotic fluid stem cell extracellular vesicle treatment. Sci Adv. 2024;10:eadn5405.
9. Atukorala I, Hannan N, Hui L. Immersed in a reservoir of potential: amniotic fluid-derived extracellular vesicles. J Transl Med. 2024;22:348.
10. Johnson J, Shojaee M, Mitchell Crow J, Khanabdali R. From mesenchymal stromal cells to engineered extracellular vesicles: a new therapeutic paradigm. Front Cell Dev Biol. 2021;9:705676.
11. Lightner AL, Sengupta V, Qian S, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19: a randomized, placebo-controlled dosing clinical trial. Chest. 2023;164:1444-53.
12. Rezaei S, Nilforoushzadeh MA, Amirkhani MA, Moghadasali R, Taghiabadi E, Nasrabadi D. Preclinical and clinical studies on the use of extracellular vesicles derived from mesenchymal stem cells in the treatment of chronic wounds. Mol Pharm. 2024;21:2637-58.
13. Mitrani MI, Bellio MA, Meglin A, et al. Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologic. Respir Med Case Rep. 2021;34:101502.
14. Mitrani MI, Bellio MA, Sagel A, et al. Case report: administration of amniotic fluid-derived nanoparticles in three severely Ill COVID-19 patients. Front Med. 2021;8:583842.
15. Deprest J, Brady P, Nicolaides K, et al. Prenatal management of the fetus with isolated congenital diaphragmatic hernia in the era of the TOTAL trial. Semin Fetal Neonatal Med. 2014;19:338-48.
16. Jani JC, Nicolaides KH, Gratacós E, et al. Severe diaphragmatic hernia treated by fetal endoscopic tracheal occlusion. Ultrasound Obstet Gynecol. 2009;34:304-10.
17. Mashiach S, Barkai G, Sack J, Stern E, Goldman B, Serr DM. Enhancement of fetal lung maturity by intra-amniotic administration of thyroid hormone. Am J Obstet Gynecol. 1978;130:289-93.
18. Lightner ES, Fismer FA, Giles H, Woolfenden J. Intra-amniotic injection of thyroxine (T4Y to a human fetus. Evidence for conversion of T4 to reverse T3. Am J Obstet Gynecol. 1977;127:487-90.
19. Margolis CA, Schneider P, Huttner K, et al. Prenatal treatment of X-linked hypohidrotic ectodermal dysplasia using recombinant ectodysplasin in a canine model. J Pharmacol Exp Ther. 2019;370:806-13.
20. Wen F, Tang X, Xu L, Qu H. Comparison of single-nucleus and single-cell transcriptomes in hepatocellular carcinoma tissue. Mol Med Rep. 2022;26:339.
21. Haque A, Engel J, Teichmann SA, Lönnberg T. A practical guide to single-cell RNA-sequencing for biomedical research and clinical applications. Genome Med. 2017;9:75.
22. Cheng K, Kalluri R. Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics. J Extracell Vesicles. 2023;2:100029.
23. Russell AL, Lefavor RC, Zubair AC. Characterization and cost-benefit analysis of automated bioreactor-expanded mesenchymal stem cells for clinical applications. Transfusion. 2018;58:2374-82.
24. Wiest EF, Zubair AC. Generation of current good manufacturing practices-grade mesenchymal stromal cell-derived extracellular vesicles using automated bioreactors. Biology. 2025;14:313.
25. Doktor F, Figueira RL, Fortuna V, et al. Amniotic fluid stem cell extracellular vesicles promote lung development via TGF-beta modulation in a fetal rat model of oligohydramnios. J Control Release. 2025;377:427-41.
26. Qiu G, Zheng G, Ge M, et al. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019;10:359.
